Company Overview And Recent Highlights

WEB Matinas BioPharma: Delivering Groundbreaking Therapies

Company Overview and Recent Highlights

WEB Matinas BioPharma is a leading biopharmaceutical company dedicated to developing innovative therapies that address significant unmet medical needs. The company's LNC Platform for the Delivery of Small Oligonucleotides has gained recognition, with two key programs recently featured as part of the company's pipeline.

Matinas BioPharma recently reported its second-quarter financial results for 2024, showcasing continued progress in its research and development initiatives.

Upcoming Milestones and Future Prospects

Planned Development Programs and Operations

The company's recent 10 million financing is expected to provide funding for its planned development programs and ongoing operations. This investment underscores the confidence investors have in Matinas BioPharma's potential.

Conference Call Announcement

Matinas BioPharma will host a conference call on August 7, 2024, at 7:00 AM EDT to discuss its second-quarter results and provide an update on its business strategy.

Conclusion

WEB Matinas BioPharma is poised for continued growth and innovation in the biopharmaceutical industry. With a robust pipeline and a strong financial position, the company is well-positioned to deliver groundbreaking therapies that improve patients' lives.